课题基金 / 基金详情

Development of cell therapies using reversibly immortalized human pancreatic beta cell lines

Development of cell therapies using reversibly immortalized human pancreatic beta cell lines
使用可逆永生化人胰腺β细胞系开发细胞疗法
批准号:
16390380
负责人:
KOBAYASHI Naoya
金额:
$9.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

KOBAYASHI Naoya的其他基金

相关文献

中文摘要
翻译
用UW溶液解冻冷冻保存的胰岛细胞后,胰岛细胞显示出有效的单层形成,并促进了慢病毒介导的有效转导。利用来源于804G细胞的细胞外基质有效地形成了小鼠胰岛的单层。我们成功地制作了糖尿病猪模型来进行全胰腺切除术。这些糖尿病猪在术后10天内死于酮症酸中毒。该模型将有助于评估糖尿病靶向细胞治疗的疗效。人类胰腺β细胞系在功能上与原代β细胞相当,目前还没有发现。我们用含有类人猿病毒40大T抗原(SV40T)和人端粒酶逆转录酶(hTERT) cdna的逆转录病毒载体转染原代人β细胞,建立了一个可逆永生化的人β细胞克隆(NAKT-15),该逆转录病毒载体的两侧是配对重组靶loxPs,允许Cre重组酶删除SV40T和hTERT基因。恢复的NAKT-15细胞表达β细胞转录因子(isl1, pax6, nkx6.1,Pdx-1),激素原转化酶1/3和2,分泌颗粒蛋白,并分泌胰岛素以响应葡萄糖,类似于正常的人胰岛。将NAKT-15细胞移植到链脲佐菌素诱导的糖尿病SCID小鼠体内,2周内血糖得到完全控制;小鼠保持血糖正常的时间超过30周。β细胞系的建立是通过移植治疗糖尿病的潜在一步。
英文摘要
After thawing the cryopreserved islets with UW solution, the islet cells showed an efficient monolayer formation and facilitated effective lentivirus-mediated transduction. Monolayer formation of mouse islets was efficiently achieved by the use of extracellular matrices derived from 804G cells. We successfully made a diabetes model in pigs to perform total pancreatectomy. Such diabetic pigs died of ketoacidosis within 10 days after surgery. The model would be useful to assess the efficacy of diabetes-targeted cell therapies. A human pancreatic beta cell line that is functionally equivalent to primary beta cells has not been available. We established a reversibly immortalized human beta cell clone (NAKT-15) by transfection of primary human beta cells with a retroviral vector containing simian virus 40 large T antigen (SV40T) and human telomerase reverse transcriptase (hTERT) cDNAs flanked by paired recombination target loxPs, which allows deletion of SV40T and hTERT genes by Cre recombinase. Reverted NAKT-15 cells expressed beta cell transcription factors (Isl-1,Pax 6,Nkx 6.1,Pdx-1), prohormone convertases 1/3 and 2, and secretory granule proteins, and secreted insulin in response to glucose, similar to normal human islets. Transplantation of NAKT-15 cells into streptozotocin-induced diabetic SCID mice resulted in perfect control of blood glucose within 2 weeks ; mice remained normoglycemic for longer than 30 weeks. The establishment of a beta cell line is one step toward the potential cure of diabetes by transplantation.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Maintenance of glucose-sensitive insulin secretion of cryopreserved human islets with University of Wisconsin solution and ascorbic acid-2 glucoside.
使用威斯康星大学溶液和抗坏血酸 2 葡萄糖苷维持冷冻保存的人胰岛的葡萄糖敏感性胰岛素分泌。
DOI: --
发表时间: 2004
期刊: Artificial Organs 28(6)
影响因子: --
作者: [Arata T, Okitsu T, Fukazawa T, Ikeda H, Kobayashi K, Chen Y, Kosaka Y, Narushima M, Matsuoka J, Yamamoto I, Tanaka N, Lakey RT J, Kobayashi N]
通讯作者: Kobayashi N
Establishment of insulin-secreting human cell lines for diabetes-targeted cell therapies.
建立用于糖尿病靶向细胞疗法的胰岛素分泌人类细胞系。
DOI: --
发表时间: 2005
期刊: Transplantation Now 18(4)
影响因子: --
作者: [Kobayashi N, Okitsu T, Chen Y, Yamatsuji T, Shirakawa Y, Inai K, Akasu H, Tanaka N]
通讯作者: Tanaka N
Transduction of human islets with the lentiviral vector.
用慢病毒载体转导人类胰岛。
DOI: --
发表时间: 2004
期刊: Transplantation Proceedings 36(7)
影响因子: --
作者: [Kobayashi N, Okitsu T, Chen Y, Yamatsuji T, Shirakawa Y, Inai K, Akasu H, Tanaka N, Takahashi T., Kondo N, Naoya Kobayashi]
通讯作者: Naoya Kobayashi
DOI: 10.1111/j.1525-1594.2004.00002.x
发表时间: 2004-11-01
期刊: ARTIFICIAL ORGANS
影响因子: 2.4
作者: [Kobayashi, K, Kobayashi, N, Tanaka, N]
通讯作者: Tanaka, N
Structural transition of de novo proteins and reconstruction of protein nanobuilding block complexes.
Basic research for common language discovery and creative dance development in the Asian dance culture area plan
  • 批准号:
    25370182
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2013
  • 负责人:
    KOBAYASHI Naoya
  • 依托单位:
A basic study on the development of bioartificial pancreas using a highly differentiated human pancreatic beta cell line.
  • 批准号:
    18390347
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $11.5万
  • 财政年份:
    2006
  • 负责人:
    KOBAYASHI Naoya
  • 依托单位: